1 Introduction to Research & Analysis Reports
1.1 Ocular Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ocular Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ocular Drug Delivery Overall Market Size
2.1 Global Ocular Drug Delivery Market Size: 2022 VS 2029
2.2 Global Ocular Drug Delivery Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Ocular Drug Delivery Sales: 2018-2029
3 Company Landscape
3.1 Top Ocular Drug Delivery Players in Global Market
3.2 Top Global Ocular Drug Delivery Companies Ranked by Revenue
3.3 Global Ocular Drug Delivery Revenue by Companies
3.4 Global Ocular Drug Delivery Sales by Companies
3.5 Global Ocular Drug Delivery Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Ocular Drug Delivery Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Ocular Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Ocular Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Ocular Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Ocular Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Ocular Drug Delivery Market Size Markets, 2022 & 2029
4.1.2 Ocular Insert
4.1.3 Iontophoresis
4.1.4 Intraocular Implants
4.1.5 In Situ Gel & Punctal Plugs
4.1.6 Others
4.2 By Type – Global Ocular Drug Delivery Revenue & Forecasts
4.2.1 By Type – Global Ocular Drug Delivery Revenue, 2018-2023
4.2.2 By Type – Global Ocular Drug Delivery Revenue, 2024-2029
4.2.3 By Type – Global Ocular Drug Delivery Revenue Market Share, 2018-2029
4.3 By Type – Global Ocular Drug Delivery Sales & Forecasts
4.3.1 By Type – Global Ocular Drug Delivery Sales, 2018-2023
4.3.2 By Type – Global Ocular Drug Delivery Sales, 2024-2029
4.3.3 By Type – Global Ocular Drug Delivery Sales Market Share, 2018-2029
4.4 By Type – Global Ocular Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Ocular Drug Delivery Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Ophthalmic Clinics
5.1.5 Homecare Settings
5.2 By Application – Global Ocular Drug Delivery Revenue & Forecasts
5.2.1 By Application – Global Ocular Drug Delivery Revenue, 2018-2023
5.2.2 By Application – Global Ocular Drug Delivery Revenue, 2024-2029
5.2.3 By Application – Global Ocular Drug Delivery Revenue Market Share, 2018-2029
5.3 By Application – Global Ocular Drug Delivery Sales & Forecasts
5.3.1 By Application – Global Ocular Drug Delivery Sales, 2018-2023
5.3.2 By Application – Global Ocular Drug Delivery Sales, 2024-2029
5.3.3 By Application – Global Ocular Drug Delivery Sales Market Share, 2018-2029
5.4 By Application – Global Ocular Drug Delivery Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Ocular Drug Delivery Market Size, 2022 & 2029
6.2 By Region – Global Ocular Drug Delivery Revenue & Forecasts
6.2.1 By Region – Global Ocular Drug Delivery Revenue, 2018-2023
6.2.2 By Region – Global Ocular Drug Delivery Revenue, 2024-2029
6.2.3 By Region – Global Ocular Drug Delivery Revenue Market Share, 2018-2029
6.3 By Region – Global Ocular Drug Delivery Sales & Forecasts
6.3.1 By Region – Global Ocular Drug Delivery Sales, 2018-2023
6.3.2 By Region – Global Ocular Drug Delivery Sales, 2024-2029
6.3.3 By Region – Global Ocular Drug Delivery Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Ocular Drug Delivery Revenue, 2018-2029
6.4.2 By Country – North America Ocular Drug Delivery Sales, 2018-2029
6.4.3 US Ocular Drug Delivery Market Size, 2018-2029
6.4.4 Canada Ocular Drug Delivery Market Size, 2018-2029
6.4.5 Mexico Ocular Drug Delivery Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Ocular Drug Delivery Revenue, 2018-2029
6.5.2 By Country – Europe Ocular Drug Delivery Sales, 2018-2029
6.5.3 Germany Ocular Drug Delivery Market Size, 2018-2029
6.5.4 France Ocular Drug Delivery Market Size, 2018-2029
6.5.5 U.K. Ocular Drug Delivery Market Size, 2018-2029
6.5.6 Italy Ocular Drug Delivery Market Size, 2018-2029
6.5.7 Russia Ocular Drug Delivery Market Size, 2018-2029
6.5.8 Nordic Countries Ocular Drug Delivery Market Size, 2018-2029
6.5.9 Benelux Ocular Drug Delivery Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Ocular Drug Delivery Revenue, 2018-2029
6.6.2 By Region – Asia Ocular Drug Delivery Sales, 2018-2029
6.6.3 China Ocular Drug Delivery Market Size, 2018-2029
6.6.4 Japan Ocular Drug Delivery Market Size, 2018-2029
6.6.5 South Korea Ocular Drug Delivery Market Size, 2018-2029
6.6.6 Southeast Asia Ocular Drug Delivery Market Size, 2018-2029
6.6.7 India Ocular Drug Delivery Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Ocular Drug Delivery Revenue, 2018-2029
6.7.2 By Country – South America Ocular Drug Delivery Sales, 2018-2029
6.7.3 Brazil Ocular Drug Delivery Market Size, 2018-2029
6.7.4 Argentina Ocular Drug Delivery Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Ocular Drug Delivery Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Ocular Drug Delivery Sales, 2018-2029
6.8.3 Turkey Ocular Drug Delivery Market Size, 2018-2029
6.8.4 Israel Ocular Drug Delivery Market Size, 2018-2029
6.8.5 Saudi Arabia Ocular Drug Delivery Market Size, 2018-2029
6.8.6 UAE Ocular Drug Delivery Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 OCULAR THERAPEUTIX, INC
7.1.1 OCULAR THERAPEUTIX, INC Company Summary
7.1.2 OCULAR THERAPEUTIX, INC Business Overview
7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Major Product Offerings
7.1.4 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.1.5 OCULAR THERAPEUTIX, INC Key News & Latest Developments
7.2 Alimera Sciences
7.2.1 Alimera Sciences Company Summary
7.2.2 Alimera Sciences Business Overview
7.2.3 Alimera Sciences Ocular Drug Delivery Major Product Offerings
7.2.4 Alimera Sciences Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.2.5 Alimera Sciences Key News & Latest Developments
7.3 Allergan, Plc
7.3.1 Allergan, Plc Company Summary
7.3.2 Allergan, Plc Business Overview
7.3.3 Allergan, Plc Ocular Drug Delivery Major Product Offerings
7.3.4 Allergan, Plc Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.3.5 Allergan, Plc Key News & Latest Developments
7.4 EyeGate Pharma
7.4.1 EyeGate Pharma Company Summary
7.4.2 EyeGate Pharma Business Overview
7.4.3 EyeGate Pharma Ocular Drug Delivery Major Product Offerings
7.4.4 EyeGate Pharma Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.4.5 EyeGate Pharma Key News & Latest Developments
7.5 Valeant Pharmaceuticals International, Inc
7.5.1 Valeant Pharmaceuticals International, Inc Company Summary
7.5.2 Valeant Pharmaceuticals International, Inc Business Overview
7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Major Product Offerings
7.5.4 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.5.5 Valeant Pharmaceuticals International, Inc Key News & Latest Developments
7.6 Envisia Therapeutics
7.6.1 Envisia Therapeutics Company Summary
7.6.2 Envisia Therapeutics Business Overview
7.6.3 Envisia Therapeutics Ocular Drug Delivery Major Product Offerings
7.6.4 Envisia Therapeutics Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.6.5 Envisia Therapeutics Key News & Latest Developments
7.7 Clearside Biomedical
7.7.1 Clearside Biomedical Company Summary
7.7.2 Clearside Biomedical Business Overview
7.7.3 Clearside Biomedical Ocular Drug Delivery Major Product Offerings
7.7.4 Clearside Biomedical Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.7.5 Clearside Biomedical Key News & Latest Developments
7.8 Graybug Vision Inc
7.8.1 Graybug Vision Inc Company Summary
7.8.2 Graybug Vision Inc Business Overview
7.8.3 Graybug Vision Inc Ocular Drug Delivery Major Product Offerings
7.8.4 Graybug Vision Inc Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.8.5 Graybug Vision Inc Key News & Latest Developments
7.9 Taiwan Liposome Company
7.9.1 Taiwan Liposome Company Company Summary
7.9.2 Taiwan Liposome Company Business Overview
7.9.3 Taiwan Liposome Company Ocular Drug Delivery Major Product Offerings
7.9.4 Taiwan Liposome Company Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.9.5 Taiwan Liposome Company Key News & Latest Developments
7.10 Santen Pharmaceutical
7.10.1 Santen Pharmaceutical Company Summary
7.10.2 Santen Pharmaceutical Business Overview
7.10.3 Santen Pharmaceutical Ocular Drug Delivery Major Product Offerings
7.10.4 Santen Pharmaceutical Ocular Drug Delivery Sales and Revenue in Global (2018-2023)
7.10.5 Santen Pharmaceutical Key News & Latest Developments
8 Global Ocular Drug Delivery Production Capacity, Analysis
8.1 Global Ocular Drug Delivery Production Capacity, 2018-2029
8.2 Ocular Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Ocular Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Ocular Drug Delivery Supply Chain Analysis
10.1 Ocular Drug Delivery Industry Value Chain
10.2 Ocular Drug Delivery Upstream Market
10.3 Ocular Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Ocular Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の眼科用ドラッグデリバリー市場予測2023-2029：眼科インサート、イオントフォレシス、眼内インプラント、In Situゲル・涙点プラグ、その他 |
| 【英語タイトル】Ocular Drug Delivery Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5819 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：72 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の眼科用ドラッグデリバリー市場規模と予測を収録しています。・世界の眼科用ドラッグデリバリー市場：売上、2018年-2023年、2024年-2029年 ・世界の眼科用ドラッグデリバリー市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の眼科用ドラッグデリバリー市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「眼科インサート」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 眼科用ドラッグデリバリーのグローバル主要企業は、OCULAR THERAPEUTIX, INC、 Alimera Sciences、 Allergan, Plc、 EyeGate Pharma、 Valeant Pharmaceuticals International, Inc、 Envisia Therapeutics、 Clearside Biomedical、 Graybug Vision Inc、 Taiwan Liposome Company、 Santen Pharmaceuticalなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、眼科用ドラッグデリバリーのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の眼科用ドラッグデリバリー市場：タイプ別、2018年-2023年、2024年-2029年 世界の眼科用ドラッグデリバリー市場：タイプ別市場シェア、2022年 ・眼科インサート、イオントフォレシス、眼内インプラント、In Situゲル・涙点プラグ、その他 世界の眼科用ドラッグデリバリー市場：用途別、2018年-2023年、2024年-2029年 世界の眼科用ドラッグデリバリー市場：用途別市場シェア、2022年 ・病院、外来手術センター、眼科診療所、在宅医療施設 世界の眼科用ドラッグデリバリー市場：地域・国別、2018年-2023年、2024年-2029年 世界の眼科用ドラッグデリバリー市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における眼科用ドラッグデリバリーのグローバル売上、2018年-2023年 ・主要企業における眼科用ドラッグデリバリーのグローバル売上シェア、2022年 ・主要企業における眼科用ドラッグデリバリーのグローバル販売量、2018年-2023年 ・主要企業における眼科用ドラッグデリバリーのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 OCULAR THERAPEUTIX, INC、 Alimera Sciences、 Allergan, Plc、 EyeGate Pharma、 Valeant Pharmaceuticals International, Inc、 Envisia Therapeutics、 Clearside Biomedical、 Graybug Vision Inc、 Taiwan Liposome Company、 Santen Pharmaceutical ************************************************************* ・調査・分析レポートの概要 眼科用ドラッグデリバリー市場の定義 市場セグメント 世界の眼科用ドラッグデリバリー市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の眼科用ドラッグデリバリー市場規模 世界の眼科用ドラッグデリバリー市場規模：2022年 VS 2029年 世界の眼科用ドラッグデリバリー市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの眼科用ドラッグデリバリーの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の眼科用ドラッグデリバリー製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：眼科インサート、イオントフォレシス、眼内インプラント、In Situゲル・涙点プラグ、その他 眼科用ドラッグデリバリーのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、外来手術センター、眼科診療所、在宅医療施設 眼科用ドラッグデリバリーの用途別グローバル売上・予測 ・地域別市場分析 地域別眼科用ドラッグデリバリー市場規模 2022年と2029年 地域別眼科用ドラッグデリバリー売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） OCULAR THERAPEUTIX, INC、 Alimera Sciences、 Allergan, Plc、 EyeGate Pharma、 Valeant Pharmaceuticals International, Inc、 Envisia Therapeutics、 Clearside Biomedical、 Graybug Vision Inc、 Taiwan Liposome Company、 Santen Pharmaceutical ... |
This report aims to provide a comprehensive presentation of the global market for Ocular Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Drug Delivery. This report contains market size and forecasts of Ocular Drug Delivery in global, including the following market information:
Global Ocular Drug Delivery Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Ocular Drug Delivery Market Sales, 2018-2023, 2024-2029, (K Doses)
Global top five Ocular Drug Delivery companies in 2022 (%)
The global Ocular Drug Delivery market was valued at US$ 25380 million in 2022 and is projected to reach US$ 34760 million by 2029, at a CAGR of 4.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Ocular Insert Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ocular Drug Delivery include OCULAR THERAPEUTIX, INC, Alimera Sciences, Allergan, Plc, EyeGate Pharma, Valeant Pharmaceuticals International, Inc, Envisia Therapeutics, Clearside Biomedical, Graybug Vision Inc and Taiwan Liposome Company, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ocular Drug Delivery manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Drug Delivery Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, by Type, 2022 (%)
Ocular Insert
Iontophoresis
Intraocular Implants
In Situ Gel & Punctal Plugs
Others
Global Ocular Drug Delivery Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics
Homecare Settings
Global Ocular Drug Delivery Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Doses)
Global Ocular Drug Delivery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Drug Delivery revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Ocular Drug Delivery revenues share in global market, 2022 (%)
Key companies Ocular Drug Delivery sales in global market, 2018-2023 (Estimated), (K Doses)
Key companies Ocular Drug Delivery sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
OCULAR THERAPEUTIX, INC
Alimera Sciences
Allergan, Plc
EyeGate Pharma
Valeant Pharmaceuticals International, Inc
Envisia Therapeutics
Clearside Biomedical
Graybug Vision Inc
Taiwan Liposome Company
Santen Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ocular Drug Delivery, market overview.
Chapter 2: Global Ocular Drug Delivery market size in revenue and volume.
Chapter 3: Detailed analysis of Ocular Drug Delivery manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Drug Delivery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ocular Drug Delivery capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の眼科用ドラッグデリバリー市場予測2023-2029：眼科インサート、イオントフォレシス、眼内インプラント、In Situゲル・涙点プラグ、その他] (コード：MMG23JU5819)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の眼科用ドラッグデリバリー市場予測2023-2029：眼科インサート、イオントフォレシス、眼内インプラント、In Situゲル・涙点プラグ、その他]についてメールでお問い合わせ |
